Advertisement
Singapore markets close in 4 hours 41 minutes
  • Straits Times Index

    3,193.66
    +38.97 (+1.24%)
     
  • Nikkei

    38,113.99
    +152.19 (+0.40%)
     
  • Hang Seng

    16,469.29
    +217.45 (+1.34%)
     
  • FTSE 100

    7,847.99
    +27.63 (+0.35%)
     
  • Bitcoin USD

    61,873.78
    -1,877.32 (-2.94%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • Dow

    37,753.31
    -45.66 (-0.12%)
     
  • Nasdaq

    15,683.37
    -181.88 (-1.15%)
     
  • Gold

    2,388.20
    -0.20 (-0.01%)
     
  • Crude Oil

    82.89
    +0.20 (+0.24%)
     
  • 10-Yr Bond

    4.5850
    -0.0740 (-1.59%)
     
  • FTSE Bursa Malaysia

    1,543.35
    +2.93 (+0.19%)
     
  • Jakarta Composite Index

    7,166.23
    +35.39 (+0.50%)
     
  • PSE Index

    6,532.44
    +82.40 (+1.28%)
     

Why Amarin Stock Tumbled in November

Why Amarin Stock Tumbled in November

Shares of the cardiovascular disease specialist Amarin (NASDAQ: AMRN) lost approximately a quarter of their value during the month of November, according to data from S&P Global Market Intelligence. Rather, Amarin's stock appears to have simply followed the broader biotech space downward last month. Amarin's shares, in particular, were probably a victim of year-end tax-loss selling last month.